Lazard Asset Management LLC增持国药控股(01099)约116.3万...

Group 1 - Lazard Asset Management LLC increased its stake in China National Pharmaceutical Group (国药控股) by acquiring 1.16304 million shares at a price of HKD 20.699 per share, totaling approximately HKD 24.0738 million [1] - Following the acquisition, Lazard's total shareholding in China National Pharmaceutical Group reached approximately 148 million shares, representing an ownership stake of 11.06% [1]